S5:E218 David delivers The Weekly Update in Venture and previews the upcoming interview with Scott Pancoast, Executive Chairman of Atticus Pharma. He outlines Atticus’s plan to disrupt Immunodermatology with 2 innovative drug formulations using a drug platform model to spin out IP protected drugs while continuing to grow the platform model. (recorded 3.8.26)
Follow David on X at https://x.com/DGRollingSouth
Connect On LinkedIn with David at https://www.linkedin.com/in/davidgrisell/
Follow Paul on X at https://x.com/PalmettoAngel
Connect On LinkedIn with Paul at
https://www.linkedin.com/in/paulclarkprivateequity/
We invite your feedback and suggestions at www.ventureinthesouth.com or email david@ventureinthesouth.com.
